The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial.
BACKGROUND: Many patients with suspected malaria in sub-Saharan Africa seek treatment from private providers, but this sector suffers from sub-standard medicine dispensing practices. To improve the quality of care received for presumptive malaria from the highly accessed private retail sector in wes...
Main Authors: | Kangwana, B, Kedenge, S, Noor, A, Alegana, V, Nyandigisi, A, Pandit, J, Fegan, G, Todd, J, Snow, R, Goodman, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2013
|
Similar Items
-
The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
by: Kangwana, B, et al.
Published: (2011) -
Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya
by: Kedenge, S, et al.
Published: (2013) -
IMPACT OF SUBSIDIZED ARTEMETHER-LUMEFANTRINE (AL) IN THE RETAIL SECTOR ON COVERAGE OF PROMPT EFFECTIVE TREATMENT OF CHILDREN UNDER FIVE IN KENYA: A CLUSTER RANDOMIZED CONTROLLED TRIAL
by: Kangwana, B, et al.
Published: (2010) -
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
by: Amin, A, et al.
Published: (2007) -
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
by: Amin, A, et al.
Published: (2007)